Skip to main content
. 2023 Nov 20;32(1):74–83. doi: 10.1016/j.ymthe.2023.11.022

Table 5.

In vivo expression of GOI detected by ligand-receptor binding ELISA

AAV type Bioreactor scale Aflibercept (pg/eye)
28 days post@4E8
Sf9-rAAV 2 L 118.1 ± 78
HEK-rAAV 10 L 135.0 ± 49

At 28 days after intravitreal dosing of 4 × 108 vg, transgene expression in the whole eye was measured by ELISA.